- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.10. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on October 23, 2026: Zomedica's Clinical Program: How Evidence Drives Adoption | 520 | ACCESS Newswire | October session to show how veterinarian-led clinical studies build the evidence behind Zomedica's PulseVet, VetGuardian PLUS, and TRUFORMA product lines, and how that evidence turns into adoption,... ► Artikel lesen | |
| 22.09. | Zomedica schließt Partnerschaft mit VMG für Zugang zu über 2.000 Tierarztpraxen | 1 | Investing.com Deutsch | ||
| 22.09. | Zomedica partners with veterinary group for product access | 2 | Investing.com | ||
| ZOMEDICA Aktie jetzt für 0€ handeln | |||||
| 22.09. | Zomedica Corp.: Zomedica Announces Strategic Partnership with Veterinary Study Groups to Deliver Advanced Veterinary Technologies to Independent Practices | 671 | ACCESS Newswire | New agreement brings innovative diagnostic, shock wave therapy, and remote monitoring solutions to more than 2,000 member practices across the United States ANN ARBOR, MI / ACCESS Newswire / September... ► Artikel lesen | |
| 09.09. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on September 25, 2026: Inside Zomedica's Marketing Engine: How Demand Becomes Revenue | 824 | ACCESS Newswire | September session to spotlight how Zomedica's marketing function creates demand, equips the field, and supports utilization across the company's diagnostic and therapeutic portfolios ANN ARBOR, MI /... ► Artikel lesen | |
| 13.08. | Zomedica Corp.: Zomedica Announces Strategic Collaboration with Boehringer Ingelheim Animal Health Canada Inc. to Expand Equine Endocrine Diagnostic Testing Using TRUFORMA Platform | 950 | ACCESS Newswire | Collaboration with one of the world's largest animal health companies expected to accelerate TRUFORMA adoption, expand installed base, and drive recurring diagnostic revenue in Canada ANN ARBOR, MI... ► Artikel lesen | |
| 11.08. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on August 28, 2026: Zomedica International: Building a Global Platform for Veterinary Innovation | 892 | ACCESS Newswire | August session to spotlight Zomedica's international expansion strategy, distributor infrastructure, global market opportunity, and the commercial leadership driving growth across five continents ANN... ► Artikel lesen | |
| 05.08. | Zomedica Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 05.08. | Zomedica Corp.: Zomedica Announces Record Second Quarter Revenue of $9.5 Million, Up 37% Year-Over-Year, Net Loss Reduced 49%, with $44.1 Million in Liquidity | 580 | ACCESS Newswire | Zomedica surpasses $9 million in second quarter revenue for the first time while extending its record of consecutive year-over-year revenue growth to 22 quarters. ANN ARBOR, MI / ACCESS Newswire / August... ► Artikel lesen | |
| 05.08. | Zomedica Corp. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 04.08. | Zomedica Corp.: Zomedica Launches the PulseVet Acoustic Muffler Accessory for PulseVet Shock Wave System | 454 | ACCESS Newswire | The accessory reduces sound in the treatment environment while maintaining the trusted efficacy of PulseVet shock wave therapy ANN ARBOR, MI / ACCESS Newswire / August 4, 2026 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| 15.07. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on July 24, 2026: Zomedica's Sales Organization - From Strategy to the Clinic | 590 | ACCESS Newswire | July session to spotlight the specialized, coordinated commercial organization that turns product innovation into clinical adoption, sustained utilization, and long-term recurring revenue ANN ARBOR... ► Artikel lesen | |
| 25.06. | Zomedica Corp.: Zomedica's Assisi Loop Products Designated "Fear Free" as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC | 438 | ACCESS Newswire | Collaboration with Fear Free and Zomedica reinforces Assisi Loop tPEMF therapy as a low-stress option for pets. ANN ARBOR, MI / ACCESS Newswire / June 25, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen | |
| 11.06. | Zomedica Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 10.06. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on June 26, 2026: The Five Pillars of Zomedica - Framework for Clinical Value and Shareholder Returns | 467 | ACCESS Newswire | June session to present the strategic framework behind every Zomedica product and investment decision, connecting pet care outcomes, veterinary practice performance, and long-term recurring revenue... ► Artikel lesen | |
| 20.05. | Zomedica Corp.: Zomedica's PulseVet System Repeats as Official Shock Wave of the United States Eventing Association | 493 | ACCESS Newswire | Collaboration with USEA for Zomedica's PulseVet shock wave system will increase brand awareness among Eventing enthusiasts. ANN ARBOR, MI / ACCESS Newswire / May 20, 2026 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| 14.05. | Zomedica Corp.: Zomedica Announces "Fifth Friday at Four" Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market | 1.050 | ACCESS Newswire | May session to review Q1 2026 financial results alongside an investor-focused look at the companion animal market for veterinary technology and Zomedica's integrated small-animal portfolio, spanning... ► Artikel lesen | |
| 06.05. | Zomedica Corp.: Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity | 1.075 | ACCESS Newswire | Zomedica surpasses $8 million in first quarter revenue for the first time and delivers record year-over-year revenue for 21st straight quarter. ANN ARBOR, MI / ACCESS Newswire / May 6, 2026 / Zomedica... ► Artikel lesen | |
| 06.05. | Zomedica reports Q1 results | 7 | Seeking Alpha | ||
| 06.05. | Zomedica Corp. - 8-K, Current Report | 3 | SEC Filings |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 41,470 | +2,14 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,890 | +0,70 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS | 47,000 | +1,44 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 61,55 | +3,48 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| GERRESHEIMER | 31,900 | -1,24 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
23.10.2026 / 11:39 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 34,760 | +0,12 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Carl Zeiss Meditec auf "Underweight" mit einem Kursziel von 18,10 Euro belassen. Für die Quartalszahlen am 10. Dezember liege er beim Umsatz auf... ► Artikel lesen | |
| CONCENTRA GROUP | 41,300 | +1,75 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| BILLIONTOONE | 114,75 | +0,66 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,250 | +1,04 % | Needham initiates Alignment Healthcare stock rating at Hold | ||
| HEARTFLOW | 59,69 | +1,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| ESSILORLUXOTTICA | 178,65 | -1,00 % | DEUTSCHE BANK RESEARCH stuft EssilorLuxottica auf 'Buy' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für EssilorLuxottica von 157 auf 197 Euro angehoben und die Aktien von "Hold" auf "Buy" hochgestuft. Es sei wieder an der Zeit... ► Artikel lesen | |
| NUWELLIS, INC | 6,465 | +19,50 % | Nuwellis: Interview With President And CEO Mike McCormick About Precision Fluid Management And Cardiorenal Care | ||
| KESTRA MEDICAL TECHNOLOGIES | 30,200 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,605 | +1,57 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| INTUITIVE SURGICAL | 401,70 | +0,80 % | ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes? |
Das Unternehmen ZOMEDICA CORP kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZOMEDICA CORP finden Sie auf Wallstreet Online.